P
PYXS icon

Pfizer’s Pyxis Oncology PYXS Stock Holding History

Pfizer’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Hold
7,032,770
– – 11.43% 4
2026
Q1 		$9.21M Hold
7,032,770
– – 3.86% 7
2025
Q4 		$8.09M Hold
7,032,770
– – 3.42% 7
2025
Q3 		$15.6M Hold
7,032,770
– – 3.57% 7
2025
Q2 		$7.74M Hold
7,032,770
– – 1.34% 7
2025
Q1 		$6.89M Hold
7,032,770
– – 1.38% 9
2024
Q4 		$11M Buy
+7,032,770
New +$20.3M 0.42% 10

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Pfizer's PYXS Position: Q2 2026 in Review

Pfizer held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 7,032,770 shares worth $19.5M. The position accounts for 11.43% of the portfolio, ranked #4.

Pfizer first reported a position in PYXS in Q4 2024 and has held it in 7 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Pfizer held 7,032,770 shares of Pyxis Oncology worth $19.5M as of Q2 2026.
  • Pfizer left its Pyxis Oncology share count unchanged in Q2 2026.
  • Pyxis Oncology made up 11.43% of Pfizer's portfolio in Q2 2026, its #4 holding.
  • Pfizer first reported a position in Pyxis Oncology in Q4 2024 and has held it in 7 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.